LabCorp Launches New Enhanced Report For Medical Drug Monitoring

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) announced today that MedTox Laboratories (MedTox), a member of the LabCorp Specialty Testing Group, introduced a new enhanced report for medical drug monitoring, the LabCorp MedWatch® ToxAssure® report. The ToxAssure report provides a visual summary of test result findings and is designed to assist physicians in monitoring drug test results relative to a patient’s prescribed medications.

Back to news